The investment landscape for advanced therapies has changed, and so must we.

Autolomous CEO Alexander Seyf joined The Medicine Maker‘s IBTV Roving Reporter series at Advanced Therapies London 2026 to discuss how tighter capital is reshaping priorities across the sector, and why scalability, cost-efficiency, and robust science are no longer just buzzwords, they’re survival requirements.

🎥 Watch the full video to hear Alexander’s perspective on how companies must adapt to build sustainable paths to patients: https://lnkd.in/gYDMHc_U